RAP 0.00% 20.5¢ raptor resources limited

********** downramps Resapp, page-113

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 1,611 Posts.
    lightbulb Created with Sketch. 30
    No need to worry if you have Technology Leadership and first mover advantage in your field and first to market and have some of the technology "patented and protected", then competition won't be a concern.

    RAP has completed clinical results already and have submitted for FDA approval and seem to be ahead of any competition that I have seen.

    Look at Cochlear, people were worried that cheap overseas hearing aids would take away market share, but Cochlear is the leader and trusted brand.
    Last edited by gemma: 05/07/16
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.